In the US stock market, a hot theme that is no less than AI semiconductors is the 'miracle drug'.In the USA, the stock prices of 'miracle drug' companies have been rising rapidly in a short period of time.In Japan, where the obese population is relatively small compared to the USA, interest is not as high, but there are listed companies domestically involved in the development of 'miracle drugs', and if commercialized, there is also the possibility that overseas investors will rush to 'buy' similar to US stocks. Pick up three promising stocks involved in the development of 'miracle drugs' domestically.
Related stocks have skyrocketed in the US in the past year or so.
'Miracle drugs' were originally developed as therapeutic drugs for diabetes and obesity patients, but when products were released targeting the general public with the promise of 'weight loss', they became a huge hit.
EspeciallyThe attention of Americans, who are said to have a 40% obesity rate, is high, with tesla CEO Elon Musk also using it.and many influencers on social media talk about 'slimming drugs'.Japanese entrepreneur Takafumi Horie, also known as HorieMon, has revealed that he has used it.。
The 'slimming drug' market is expected to grow to $100 billion (about 15 trillion yen) by 2030, about 16 times the current size...